 |
5 Products |  |
0 Diseases | | 5 Products |
|
3 Trials |  |
266 News |  |
| «123 |
- |||||||||| Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
New P2/3 trial: Phase II Study to Evaluate the Efficacy and Safety of Glassia (clinicaltrials.gov) - Dec 5, 2013
P2/3, N=192, Recruiting, Sponsor: Kamada, Ltd.
- Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Enrollment open: Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) (clinicaltrials.gov) - Nov 21, 2013
P1/2, N=24, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting --> Recruiting
- HepaGam B (hepatitis B immune globulin intravenous (human)) / Kamada
Enrollment change, Combination therapy: Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients (clinicaltrials.gov) - Oct 29, 2013
P4, N=9, Completed, Sponsor: Cangene Corporation
Not yet recruiting --> Recruiting N=31 --> 9
- HepaGam B (hepatitis B immune globulin intravenous (human)) / Kamada
Trial completion, Combination therapy: Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients (clinicaltrials.gov) - Oct 29, 2013
P4, N=9, Completed, Sponsor: Cangene Corporation
N=31 --> 9 Active, not recruiting --> Completed
- ||||| cyclophosphamide / Generic mfg.
Enrollment closed: Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma (clinicaltrials.gov) - Jun 10, 2013
P3, N=53, Active, not recruiting, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Trial completion: Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus (clinicaltrials.gov) - Feb 17, 2013
P1/2, N=24, Completed, Sponsor: Kamada, Ltd.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Trial completion: GLASSIA Infusion Rate Study (clinicaltrials.gov) - Jan 25, 2013
P4, N=30, Completed, Sponsor: Baxter Healthcare Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Prolastin-C (human alpha1-proteinase inhibitor IV) / Grifols, OrphanPacific
New P2/3 trial: Safety and Efficacy of (?1Proteinase Inhibitor, ?1PI) in HIV Disease (clinicaltrials.gov) - Nov 20, 2012
P2/3, N=20, Recruiting, Sponsor: AIDS Community Research Initiative of America
- | Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
New P4 trial: GLASSIA Infusion Rate Study (clinicaltrials.gov) - Jul 25, 2012
P4, N=30, Completed, Sponsor: Baxter Healthcare Corporation
- | Cytogam (cytomegalovirus immune globulin intravenous(human)) / Kamada
Trial initiation date: A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) (clinicaltrials.gov) - Jun 21, 2012
P3, N=800, Recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed Initiation date: Aug 2011 --> Apr 2012
- | Cytogam (cytomegalovirus immune globulin intravenous(human)) / Kamada
Enrollment open: A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) (clinicaltrials.gov) - Jun 21, 2012
P3, N=800, Recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Initiation date: Aug 2011 --> Apr 2012 Not yet recruiting --> Recruiting
- Cytogam (cytomegalovirus immune globulin intravenous(human)) / Kamada
Trial completion: The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease (clinicaltrials.gov) - Jun 21, 2012
P=N/A, N=28, Completed, Sponsor: University of Wisconsin, Madison
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
New P1/2 trial: Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) (clinicaltrials.gov) - Jan 30, 2012
P1/2, N=24, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
- | Cytogam (cytomegalovirus immune globulin intravenous(human)) / Kamada
New P4 trial: Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection (clinicaltrials.gov) - Jan 11, 2012
P4, N=40, Active, not recruiting, Sponsor: Medical University of South Carolina
- WinRho SDF (rho(d) immune globulin (human)) / Kamada
Clinical: Role of Andi-d in Dengue Fever: a Pilot Study (clinicaltrials.gov) - Sep 24, 2011
P=N/A, N=30, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
- | Nabi-HB (hepatitis B immune globulin) / ADMA Biologics
New P1/2 trial, Combination therapy: Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation (clinicaltrials.gov) - Aug 17, 2011
P1/2, N=30, Completed, Sponsor: Biotest Pharmaceuticals Corporation